Choate represented Trinity Partners, LLC in its investment from Parthenon Capital Partners.
Parthenon Capital Partners, a growth-oriented private equity firm, executed an investment in Trinity Partners, LLC, a leading commercialization strategy and analytics firm that partners with life sciences companies to help bring innovative treatments to market. The current Trinity management team will continue to lead the organization post-closing.
Terms of the investment were not disclosed. Baird acted as exclusive financial advisor to Trinity in connection with the transaction.
Trinity Partners is a trusted life sciences strategy consulting firm that takes a personalized approach to working with pharmaceutical, biotech, medical device, and diagnostic clients worldwide to create evidence-based solutions that drive business strategy and impact bottom lines. The company, led by John Corcoran, David Fitzhenry, Leslie Sandberg, Fotios Kokkotos, Yogesh Soneji, Neal Dunn, Hernan Sanchez, Stephen Fleming and Aparna Deshpande, is based in Waltham.
Parthenon Capital Partners is a leading growth-oriented private equity firm based in Boston and San Francisco. Parthenon utilizes niche industry expertise and a deep execution team to invest in growth companies in technology and tech-enabled services industries. Parthenon seeks to be an active and aligned partner to management, either through recapitalization transactions or by backing strong executive teams. Parthenon focuses on healthcare services and financial services with a particular expertise in HCIT, payments and financial technology.
Choate represented Trinity Partners, LLC with a team including John A. Meltaus (Picture), Timothy J. Becker, Alison F. Reif, E. Peter Alvarez and Zachary Rosen.
Law Firms: Choate;
Clients: Trinity Partners, LLC;